Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Veracyte Inc
(NQ:
VCYT
)
22.88
-0.52 (-2.22%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 17, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Veracyte Inc
< Previous
1
2
3
4
5
6
7
8
9
Next >
Stocks That Hit 52-Week Lows On Thursday
May 05, 2022
During Thursday, 351 stocks hit new 52-week lows.
Via
Benzinga
Analyst Ratings for Veracyte
May 04, 2022
Within the last quarter, Veracyte (NASDAQ:VCYT) has observed the following analyst ratings:
Via
Benzinga
Recap: Veracyte Q4 Earnings
February 28, 2022
Veracyte (NASDAQ:VCYT) reported its Q4 earnings results on Monday, February 28, 2022 at 04:05 PM. Here's what investors need to know about the announcement. Earnings Veracyte...
Via
Benzinga
Earnings Scheduled For February 28, 2022
February 28, 2022
Companies Reporting Before The Bell • Lexicon Pharmaceuticals (NASDAQ:LXRX) is estimated to report earnings for its fourth quarter. • Praxis Precision Medicine (...
Via
Benzinga
Veracyte Announces New Consensus Data from PROCURE Study Presented at ESMO Breast Cancer 2022
May 04, 2022
From
Veracyte, Inc.
Via
Business Wire
Recap: Veracyte Q1 Earnings
May 03, 2022
Veracyte (NASDAQ:VCYT) reported its Q1 earnings results on Tuesday, May 3, 2022 at 04:05 PM. Here's what investors need to know about the announcement. Earnings Veracyte beat estimated earnings by...
Via
Benzinga
Veracyte Announces First Quarter 2022 Financial Results
May 03, 2022
From
Veracyte, Inc.
Via
Business Wire
The Daily Biotech Pulse: FDA's AdComm For Acadia's Pimavanserin, Review Issues For Spero's Tebipenem Application, Cortexyme Layoffs
May 03, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours.
Via
Benzinga
Earnings Scheduled For May 3, 2022
May 03, 2022
Companies Reporting Before The Bell • Kiniksa Pharmaceuticals (NASDAQ:KNSA) is projected to report earnings for its first quarter.
Via
Benzinga
Preview: Veracyte's Earnings
May 02, 2022
Veracyte (NASDAQ:VCYT) is set to give its latest quarterly earnings report on Tuesday, 2022-05-03. Here's what investors need to know before the announcement. Analysts estimate that Veracyte will...
Via
Benzinga
Envisia Genomic Classifier Highlighted in Updated Clinical Practice Guideline Regarding Idiopathic Pulmonary Fibrosis Diagnosis
May 02, 2022
From
Veracyte, Inc.
Via
Business Wire
Veracyte Announces New Urologic Cancer Data To Be Presented at AUA 2022 International Conference
April 28, 2022
From
Veracyte, Inc.
Via
Business Wire
Veracyte Announces New Performance Data for the Percepta Nasal Swab Test To Be Presented at ATS 2022 International Conference
April 26, 2022
From
Veracyte, Inc.
Via
Business Wire
Veracyte to Release First Quarter 2022 Financial Results on May 3, 2022
April 19, 2022
From
Veracyte, Inc.
Via
Business Wire
10 Biggest Price Target Changes For Tuesday
March 01, 2022
Keybanc cut the price target on Workday, Inc. (NASDAQ: WDAY) from $345 to $312. Workday shares rose 5.7% to $242.00 in pre-market trading.
Via
Benzinga
Veracyte Appoints Annie McGuire as General Counsel
February 28, 2022
From
Veracyte, Inc.
Via
Business Wire
Veracyte Appoints Jonathan Wygant as Chief Accounting Officer
February 22, 2022
From
Veracyte, Inc.
Via
Business Wire
Veracyte to Release Fourth Quarter and Full-Year 2021 Financial Results on February 28, 2022
February 15, 2022
From
Veracyte, Inc.
Via
Business Wire
New Data Validate Clinical Utility of Veracyte’s Decipher Prostate Genomic Classifier To Help Guide Therapy In Men with Intermediate-Risk Prostate Cancer
February 14, 2022
From
Veracyte, Inc.
Via
Business Wire
Veracyte to Participate in 11th Annual SVB Leerink Global Healthcare Conference
February 08, 2022
From
Veracyte, Inc.
Via
Business Wire
Veracyte Announces New Data to be Presented at the 2022 ASCO Genitourinary (GU) Cancers Symposium
January 31, 2022
From
Veracyte, Inc.
Via
Business Wire
New Data Suggest Veracyte’s Percepta Genomic Sequencing Classifier Can Help Accelerate Timely Treatment for Patients with Early-Stage Lung Cancer
January 24, 2022
From
Veracyte, Inc.
Via
Business Wire
Stocks That Hit 52-Week Lows On Friday
January 14, 2022
During Friday's session, 445 companies made new 52-week lows. Noteable 52-Week Lows: Intuitive Surgical (NASDAQ:ISRG) is the largest company in terms of market cap to...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 7, 2022
January 07, 2022
Upgrades According to Wolfe Research, the prior rating for CVR Energy Inc (NYSE:
Via
Benzinga
Veracyte Announces Key Leadership Promotions to Advance Its Strategic Global Vision
January 06, 2022
From
Veracyte, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Thursday's Intraday Session
December 23, 2021
Gainers Pasithea Therapeutics (NASDAQ:
Via
Benzinga
Biotech Playbook 2021 Part 2: Rotation Rally Brings Relief after FED Pivot
December 22, 2021
The new aggressive Fed taper combined with a rise in interest rates for 2022 adds a new element of risk to portfolio management. Monetary policy is a headwind for 2022.
Via
Talk Markets
63 Biggest Movers From Friday
December 20, 2021
Gainers Spruce Biosciences, Inc. (NASDAQ: SPRB) jumped 102.8% to close at $5.03 on Friday after Oppenheimer initiated coverage on the stock with an Outperform rating and a $15...
Via
Benzinga
Veracyte Announces Publication of Data Demonstrating Clinical Utility of Its Envisia Genomic Classifier to Improve IPF Diagnosis
December 14, 2021
From
Veracyte, Inc.
Via
Business Wire
Biotech Playbook 2021: No Help From Small Caps In Q4
December 14, 2021
Mid-cap stock picks have done better today but are way off their 2021 highs. Cryoport and Veracyte are still up and look better technically. Quidel was up 5.48% today on Omicron concerns globally but...
Via
Talk Markets
< Previous
1
2
3
4
5
6
7
8
9
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.